Norvium Bioscience Drug Patent Portfolio

Norvium Bioscience owns 8 orange book drugs protected by 14 US patents with Accuneb having the least patent protection, holding only 1 patent. And Olux E with maximum patent protection, holding 4 patents. Given below is the list of Norvium Bioscience's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8460641 Microemulsion process and composition 05 Nov, 2028
Active
US8962000 Microemulsion and sub-micron emulsion process and compositions 31 Aug, 2025
Active
US7141237 Pharmaceutical foam 03 Feb, 2024 Expired
US7374747 Pharmaceutical foam 23 Jan, 2024 Expired
US6702997 Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma 28 Dec, 2021 Expired
US6632842 Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease 28 Dec, 2021 Expired
US6730288 Mousse composition 08 Sep, 2019 Expired
US7029659 Mousse composition 08 Sep, 2019 Expired
US7553835 Topical antifungal composition 19 Oct, 2018 Expired
US8026238 Topical antifungal composition 19 Oct, 2018 Expired
US7078058 Corticosteroid-containing pharmaceutical composition 24 May, 2017 Expired
US6126920 Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition 01 Mar, 2016 Expired
US5733569 Galenic compositions comprising calcitonin and their use 31 Mar, 2015 Expired
US5759565 Galenic compositions comprising calcitonin and their use 31 Mar, 2015 Expired


Given below is the list of recent legal activities going on the following drug patents of Norvium Bioscience.

Activity Date Patent Number
Patent litigations
Expire Patent 30 Oct, 2023 US8026238
Maintenance Fee Reminder Mailed 15 May, 2023 US8026238
Payment of Maintenance Fee, 8th Year, Large Entity 28 Sep, 2020 US8460641
Payment of Maintenance Fee, 12th Year, Large Entity 22 Oct, 2019 US7374747
File Marked Found 03 Jul, 2019 US6702997
Payment of Maintenance Fee, 8th Year, Large Entity 20 Mar, 2019 US8026238
File Marked Found 17 Oct, 2018 US6632842
File Marked Found 02 Oct, 2018 US6702997
Expire Patent 13 Aug, 2018 US7078058
Payment of Maintenance Fee, 12th Year, Large Entity 13 Apr, 2018 US7141237
Maintenance Fee Reminder Mailed 26 Feb, 2018 US7078058
Payment of Maintenance Fee, 12th Year, Large Entity 14 Sep, 2017 US7029659 (Litigated)
Change in Power of Attorney (May Include Associate POA) 14 Nov, 2016 US8026238
Email Notification 14 Nov, 2016 US8026238
Correspondence Address Change 10 Nov, 2016 US8026238


Norvium Bioscience's Drug Patent Litigations

Norvium Bioscience's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on May 23, 1994, against patent number US5759565. The petitioner , challenged the validity of this patent, with AZRIA et al as the respondent. Click below to track the latest information on how companies are challenging Norvium Bioscience's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US5759565 May, 1994 Decision
(25 Aug, 1997)
AZRIA et al


Norvium Bioscience Drug Patents' Oppositions Filed in EPO

Norvium Bioscience drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on May 14, 2014, by Generics [Uk] Limited. This opposition was filed on patent number EP05775966A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP05775966A May, 2014 Henkel AG & Co. KGaA Patent maintained as amended
EP05775966A May, 2014 Generics [UK] Limited Patent maintained as amended


Norvium Bioscience's Family Patents

Norvium Bioscience drugs have patent protection in a total of 21 countries. It's US patent count contributes only to 25.5% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Norvium Bioscience Drug List

Given below is the complete list of Norvium Bioscience's drugs and the patents protecting them.


1. Accuneb

Accuneb is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6702997 Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma 28 Dec, 2021
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Accuneb's drug page


2. Duoneb

Duoneb is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6632842 Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease 28 Dec, 2021
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Duoneb's drug page


3. Evoclin

Evoclin is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7141237 Pharmaceutical foam 03 Feb, 2024
(8 months ago)
Expired
US7374747 Pharmaceutical foam 23 Jan, 2024
(9 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Evoclin's drug page


4. Extina

Extina is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7553835 Topical antifungal composition 19 Oct, 2018
(6 years ago)
Expired
US8026238 Topical antifungal composition 19 Oct, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Extina's drug page


5. Luxiq

Luxiq is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7078058 Corticosteroid-containing pharmaceutical composition 24 May, 2017
(7 years ago)
Expired
US6126920 Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition 01 Mar, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Luxiq's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Miacalcin

Miacalcin is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5733569 Galenic compositions comprising calcitonin and their use 31 Mar, 2015
(9 years ago)
Expired
US5759565 Galenic compositions comprising calcitonin and their use 31 Mar, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Miacalcin's drug page


7. Olux

Olux is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6126920 Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition 01 Mar, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olux's drug page


8. Olux E

Olux E is protected by 4 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8460641 Microemulsion process and composition 05 Nov, 2028
(4 years from now)
Active
US8962000 Microemulsion and sub-micron emulsion process and compositions 31 Aug, 2025
(9 months from now)
Active
US6730288 Mousse composition 08 Sep, 2019
(5 years ago)
Expired
US7029659 Mousse composition 08 Sep, 2019
(5 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olux E's drug page